The recombinant form of human DNase I (Pulmozyme®, dornase alfa) hydrolyses the DNA in the purulent secretions from the airways of CF patients, reduces mucus viscoelasticity, and improves pulmonary function [322,323]. The gene discussed is DNASE1; the disease is cystic fibrosis.